Mass General Hospital

Harvard Medical School

Welcome to the MGH Center for Women’s Mental Health

Welcome

Welcome to The Ammon-Pinizzotto Center for Women’s Mental Health at MGH. Our Center, established in 1989, has been renamed following the generous gift from Carol Ammon and Dr. Marie Pinizzotto. These resources will be used to realize the overarching mission of the Center.

This website provides a range of current information including discussion of new research findings in women’s mental health and how such investigations inform day-to-day clinical practice. Despite the growing number of studies being conducted in women’s health, the clinical implications of such work are frequently controversial, leaving patients with questions regarding the most appropriate path to follow. Providing these resources to patients and their doctors so that individual clinical decisions can be made in a thoughtful and collaborative fashion dovetails with the mission of our Center.

The National Pregnancy Registry for Psychiatric Medications:

All pregnant women between the ages of 18-45 with a history of psychiatric illness are eligible to enroll in the registry. The primary goal of this Registry is to determine the frequency of major malformations, such as heart defects, cleft lip, or neural tube defects, in infants exposed to atypical antipsychotics and antidepressants during pregnancy.  We are currently seeking both controls and those being treated with atypical antipsychotics and/ or antidepressants. For more information, please visit this page, call 1-866-961-2388 or e-mail registry@womensmentalhealth.org.

Course of ADHD in Pregnancy and the Postpartum

Are you pregnant? Do you have a history of ADHD?

If you are less than 20 weeks pregnant and have a history of ADHD, you may be eligible to take part in an observational research study for women maintaining, decreasing, or discontinuing psychostimulants during pregnancy and the postpartum. Women who participate will have 6 study visits from time of enrollment (<20 weeks pregnant) to 24 weeks postpartum.  The first visit must be in-person at Massachusetts General Hospital with the option to complete the remaining visits in-person or over the phone.

For more information, please call (617)726-2912 or email the study coordinator at onoe@partners.org

 

 

 EnBrace HR for MDD Relapse Prevention in         Women Trying to Conceive and Early Pregnancy:

 

Are you pregnant or planning a pregnancy? Do you feel depressed or have a history of depression? If you are less than 28 weeks pregnant or trying to conceive and have experienced depression now or in the past, you may be eligible to take part in a research study for the treatment of depression with a prenatal supplement. For more information, please visit this page, call Taylor at 617-643-9284 or email tchurch1@partners.org

 

 

Lifestyle Intervention Research Study Opportunity:

Are you pregnant or planning to become pregnant? Do you have a history of depression? Do you want to lose weight or have a healthier lifestyle? You may be eligible to participate in a research study evaluating a new lifestyle intervention for weight loss. Participants will receive 10 sessions of therapy at no cost to you.

If you are interested in participating or would like additional information, please call Samantha at 617-643-2076.

 

The MGH Center for Women’s Mental Health

Perinatal and Reproductive Psychiatry Program

Simches Research Building

185 Cambridge St Suite 2200

Boston, MA 02114

 

To make an appointment:

Massachusetts General Hospital Clinical Program: (617) 724-7792

Location of appointments: 

Wang Ambulatory Care Center, Massachusetts General Hospital

15 Parkman St., Floor 8

Boston, MA 02114-3117 

Latest News from our Blog

  • Depression in Fathers Increases Risk for Adolescent Depression

    November 21, 2017

    According to a study published last year in the journal Pediatrics, adolescent depression is on the rise. In adolescents, the 12-month prevalence of major depression increased from 8.7% in 2005 to 11.3% in 2014.  Other studies have noted an increase in rates of suicide among adolescents, particularly girls; among girls aged 10-14, the suicide rate ...

    Read more
  • Weekly Roundup for November 17, 2017: Recent Publications in Women’s Mental Health

    November 17, 2017

    The article that received the most attention this week is one examining the risks associated with the use of stimulants to treat ADHD during pregnancy (Cohen JM et al, 2017).  There were no real surprises here, but the study suffers from many of the same shortcomings as other studies investigating the effects of other psychotropic ...

    Read more
  • Autism Spectrum Disorders and Maternal Nutrition

    November 8, 2017

    Current research suggests that autism spectrum disorders (ASD) occur as a result of events that take place during pregnancy.  While genetic factors play an important role, non-heritable risk factors contribute to a substantial proportion of ASD cases.  Maternal nutrition has been a focus of interest as a factor which may influence risk for ASD. However, ...

    Read more
  • Weekly Roundup for November 3, 2017: Recent Publications in Women’s Mental Health

    November 3, 2017

    The comorbidity of Axis I disorders in depressed pregnant women. Dindo L, Elmore A, O’Hara M, Stuart S.  Arch Womens Ment Health. 2017 Aug 25. Researchers observed high rates of anxiety disorders among women both with and without current major depression, although depressed women reported higher rates of generalized anxiety disorder and post-traumatic stress disorder. Maternal ...

    Read more
  • New Research from the CWMH: Risk of Gestational Diabetes in Women Taking Second Generation Antipsychotics During Pregnancy

    November 1, 2017

      The use of the newer “atypical” or second-generation antipsychotic (SGA) agents continues to increase.  These medications are used to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and anxiety disorders.  Although most of the women taking atypical antipsychotics are of childbearing age, our information on the reproductive safety of these ...

    Read more
  • Weekly Roundup for October 27, 2017: Recent Publications in Women’s Mental Health

    October 27, 2017

    This week, we have two studies from the Center for Women’s Mental Health — one looking at risk for gestational diabetes in women treated with second generation antipsychotic medications during pregnancy and the other on the use of vortioxetine in perimenopausal women.   Ruta Nonacs, MD PhD Gestational Weight Gain and Pre-pregnancy Body Mass Index Associated With ...

    Read more

Read more from our Blog

Recent Awards

banner_postpartum-depression

Awarded by Healthline.com

Awarded by Feedspot.com

 

 

 

 

 

 

Awarded by Feedspot.com

Awarded by Cables and Sensors